Description
Endjerix-V (HBsAg) for adults 1 ml. 20 mcg. #10 vial
Endjerix-V (HBsAg) is a vaccine indicated for adults to provide protection against hepatitis B virus infection. Each vial contains 1 ml. of the vaccine solution with a potency of 20 mcg. This product is available in a pack of 10 vials, each vial meant for a single dose administration.
Overview
Endjerix-V contains the hepatitis B surface antigen (HBsAg), a protein derived from the hepatitis B virus. When administered, this vaccine stimulates the immune system to produce antibodies against the HBsAg, providing long-term protection against hepatitis B infection. It is an essential tool in preventing the spread of hepatitis B, a potentially serious liver infection that can lead to chronic liver disease, liver cancer, and other complications.
Indications
Endjerix-V is indicated for adults who are at risk of exposure to hepatitis B virus, including healthcare workers, individuals with multiple sexual partners, injection drug users, and those with certain medical conditions that may increase their risk of infection. It is also recommended for travelers to regions where hepatitis B is prevalent.
Administration
Endjerix-V is administered as an intramuscular injection, usually in the deltoid muscle of the upper arm. The recommended dose for adults is 1 ml, containing 20 mcg of HBsAg. The vaccine should be administered according to the recommended schedule, which may involve multiple doses to ensure optimal protection.
Contraindications
Endjerix-V should not be administered to individuals who have had a severe allergic reaction to a previous dose of the vaccine or any of its components. It is also contraindicated in individuals with a history of severe allergic reactions to yeast, as some components of the vaccine may be derived from yeast.
Side Effects
Common side effects of Endjerix-V may include pain or redness at the injection site, mild fever, fatigue, and headache. These side effects are usually mild and resolve on their own within a few days. Serious side effects such as severe allergic reactions are rare but can occur in some individuals.
Storage
Endjerix-V should be stored at the recommended temperature as indicated on the packaging. It should be protected from light and kept out of reach of children. Do not freeze the vaccine, and discard any unused portion according to local regulations.
Precautions
Before administering Endjerix-V, healthcare providers should review the patient’s medical history and assess for any contraindications or precautions. Individuals with compromised immune systems or certain medical conditions may require special consideration before receiving the vaccine.
Warnings
Healthcare providers should be aware of the potential risks and benefits of Endjerix-V and communicate this information clearly to patients. In case of any adverse reactions or unexpected side effects, healthcare providers should follow the appropriate guidelines for reporting and managing such events.
Conclusion
Endjerix-V (HBsAg) is an important vaccine for adults at risk of hepatitis B infection. By stimulating the immune system to produce antibodies against the hepatitis B virus, this vaccine offers long-term protection and helps prevent the spread of this potentially serious infection. Healthcare providers should follow the recommended guidelines for administration, storage, and monitoring of patients receiving Endjerix-V to ensure its safety and efficacy.
